2002
DOI: 10.1253/circj.66.851
|View full text |Cite
|
Sign up to set email alerts
|

Overexpression of Endothelial Nitric Oxide Synthase Attenuates Cardiac Hypertrophy Induced by Chronic Isoproterenol Infusion.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
63
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 78 publications
(68 citation statements)
references
References 28 publications
5
63
0
Order By: Relevance
“…We previously reported that overexpression of eNOS attenuated cardiac hypertrophy induced by chronic isoproterenol infusion. 31 Other studies have proven that LV performance was improved and compensatory hypertrophy was reduced after MI in eNOS-overexpressing mice. 14,15 In addition, eNOS deficiency was associated with maladaptive remodeling after MI having increased cardiac hypertrophy and reduced LV function.…”
Section: Discussionmentioning
confidence: 98%
“…We previously reported that overexpression of eNOS attenuated cardiac hypertrophy induced by chronic isoproterenol infusion. 31 Other studies have proven that LV performance was improved and compensatory hypertrophy was reduced after MI in eNOS-overexpressing mice. 14,15 In addition, eNOS deficiency was associated with maladaptive remodeling after MI having increased cardiac hypertrophy and reduced LV function.…”
Section: Discussionmentioning
confidence: 98%
“…Pathological conditions, such as arterial hypertension, aorta stenosis or coarctation, called pressure overload; or conditions such as aortic failure or interatrial communication, called volume overload, can promote hypertrophy due to the increased cardiomyocyte volume, together with an increase in size and alteration in the quality of the collagen matrix components 5,7 .…”
Section: Pressure And/or Volume Overloadmentioning
confidence: 99%
“…The first evidence that the • NO can present anti-hypertrophic effects in the heart were obtained in spontaneously hypertensive rats (SHR) under chronic treatment with L-arginine 4 . Subsequently, such role of the • NO was confirmed in mice that hyper-expressed endothelial nitric oxide synthase (eNOS), in which the • NO attenuated the heart hypertrophy induced by the chronic infusion of isoprenaline (ISO) 5 , indicating that the endogenous • NO acts as a negative modulator for heart hypertrophy.…”
Section: Introductionmentioning
confidence: 95%
“…Their effects are amplified when production of atheroprotective endothelial nitric oxide (NO) is reduced by EC dysfunction. Both increased ROS and reduced endothelial NO [14][15][16][17][18][19] have been implicated in accelerating plaque progression in Apoe -/-mice and are represented in the model.…”
Section: Oxidative Stressmentioning
confidence: 99%